{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,15]],"date-time":"2026-10-15T02:21:49Z","timestamp":1792030909565,"version":"4.4.0"},"reference-count":240,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2018,5,17]],"date-time":"2018-05-17T00:00:00Z","timestamp":1526515200000},"content-version":"unspecified","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["R01AR068974, R01AI42269, R37AI49954, R01AI65687, R01AI085567, R01 AR064350"],"award-info":[{"award-number":["R01AR068974, R01AI42269, R37AI49954, R01AI65687, R01AI085567, R01 AR064350"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Immunol."],"DOI":"10.3389\/fimmu.2018.01088","type":"journal-article","created":{"date-parts":[[2018,5,17]],"date-time":"2018-05-17T09:10:51Z","timestamp":1526548251000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":202,"title":["Aberrant T Cell Signaling and Subsets in Systemic Lupus Erythematosus"],"prefix":"10.3389","volume":"9","author":[{"given":"Takayuki","family":"Katsuyama","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"George C.","family":"Tsokos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vaishali R.","family":"Moulton","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2018,5,17]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"147","DOI":"10.1038\/35100573","article-title":"From T to B and back again: positive feedback in systemic autoimmune disease","volume":"1","author":"Shlomchik","year":"2001","journal-title":"Nat Rev Immunol"},{"key":"B2","doi-asserted-by":"publisher","first-page":"2110","DOI":"10.1056\/NEJMra1100359","article-title":"Systemic lupus erythematosus","volume":"365","author":"Tsokos","year":"2011","journal-title":"N Engl J Med"},{"key":"B3","doi-asserted-by":"publisher","first-page":"2220","DOI":"10.1172\/JCI78087","article-title":"T cell signaling abnormalities contribute to aberrant immune cell function and autoimmunity","volume":"125","author":"Moulton","year":"2015","journal-title":"J Clin Invest"},{"key":"B4","doi-asserted-by":"publisher","first-page":"610","DOI":"10.3389\/fimmu.2015.00610","article-title":"Disturbed T cell signaling and altered Th17 and regulatory T cell subsets in the pathogenesis of systemic lupus erythematosus","volume":"6","author":"Rother","year":"2015","journal-title":"Front Immunol"},{"key":"B5","doi-asserted-by":"publisher","first-page":"615","DOI":"10.1016\/j.molmed.2017.05.006","article-title":"Pathogenesis of human systemic lupus erythematosus: a cellular perspective","volume":"23","author":"Moulton","year":"2017","journal-title":"Trends Mol Med"},{"key":"B6","doi-asserted-by":"publisher","first-page":"157","DOI":"10.1111\/j.1600-065X.1995.tb00069.x","article-title":"Inquiry into murine and human lupus","volume":"144","author":"Klinman","year":"1995","journal-title":"Immunol Rev"},{"key":"B7","doi-asserted-by":"publisher","first-page":"1644","DOI":"10.1002\/1529-0131(199908)42:8<1644::AID-ANR12>3.0.CO;2-L","article-title":"Th1\/Th2 balance of peripheral T helper cells in systemic lupus erythematosus","volume":"42","author":"Akahoshi","year":"1999","journal-title":"Arthritis Rheum"},{"key":"B8","doi-asserted-by":"publisher","first-page":"413","DOI":"10.1038\/312413a0","article-title":"Isolation of cDNA clones encoding the 20K T3 glycoprotein of human T-cell receptor complex","volume":"312","author":"van den Elsen","year":"1984","journal-title":"Nature"},{"key":"B9","doi-asserted-by":"crossref","first-page":"1799","DOI":"10.1002\/j.1460-2075.1986.tb04429.x","article-title":"Primary structure of the T3 gamma subunit of the T3\/T cell antigen receptor complex deduced from cDNA sequences: evolution of the T3 gamma and delta subunits","volume":"5","author":"Krissansen","year":"1986","journal-title":"EMBO J"},{"key":"B10","doi-asserted-by":"publisher","first-page":"103","DOI":"10.1146\/annurev-immunol-042617-053429","article-title":"Cell biology of T cell receptor expression and regulation","volume":"36","author":"Alcover","year":"2017","journal-title":"Annu Rev Immunol"},{"key":"B11","doi-asserted-by":"publisher","first-page":"2396","DOI":"10.1128\/MCB.00165-16","article-title":"Phosphorylation of a tyrosine residue on Zap70 by Lck and its subsequent binding via an SH2 domain may be a key gatekeeper of T cell receptor signaling in vivo","volume":"36","author":"Thill","year":"2016","journal-title":"Mol Cell Biol"},{"key":"B12","doi-asserted-by":"publisher","first-page":"371","DOI":"10.1146\/annurev.immunol.20.092601.111357","article-title":"Signal transduction mediated by the T cell antigen receptor: the role of adapter proteins","volume":"20","author":"Samelson","year":"2002","journal-title":"Annu Rev Immunol"},{"key":"B13","doi-asserted-by":"publisher","first-page":"97","DOI":"10.1615\/CritRevImmunol.2013006696","article-title":"Role of diacylglycerol kinases in T cell development and function","volume":"33","author":"Krishna","year":"2013","journal-title":"Crit Rev Immunol"},{"key":"B14","doi-asserted-by":"publisher","first-page":"1448","DOI":"10.1172\/JCI1457","article-title":"Altered pattern of TCR\/CD3-mediated protein-tyrosyl phosphorylation in T cells from patients with systemic lupus erythematosus. Deficient expression of the T cell receptor zeta chain","volume":"101","author":"Liossis","year":"1998","journal-title":"J Clin Invest"},{"key":"B15","doi-asserted-by":"publisher","first-page":"1908","DOI":"10.1002\/1529-0131(199909)42:9<1908::AID-ANR17>3.0.CO;2-7","article-title":"Diminished levels of T cell receptor zeta chains in peripheral blood T lymphocytes from patients with systemic lupus erythematosus","volume":"42","author":"Brundula","year":"1999","journal-title":"Arthritis Rheum"},{"key":"B16","doi-asserted-by":"publisher","first-page":"160","DOI":"10.1046\/j.1365-2249.2002.01833.x","article-title":"Defective expression and tyrosine phosphorylation of the T cell receptor zeta chain in peripheral blood T cells from systemic lupus erythematosus patients","volume":"129","author":"Pang","year":"2002","journal-title":"Clin Exp Immunol"},{"key":"B17","doi-asserted-by":"publisher","first-page":"259","DOI":"10.1016\/S0161-5890(98)00047-9","article-title":"The Fc receptor (FcR) gamma subunit is essential for IgE-binding activity of cell-surface expressed chimeric receptor molecules constructed from human high-affinity IgE receptor (Fc epsilon RI) alpha and FcR gamma subunits","volume":"35","author":"Suzuki","year":"1998","journal-title":"Mol Immunol"},{"key":"B18","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/s10875-005-0353-8","article-title":"Fc receptors and their role in immune regulation and autoimmunity","volume":"25","author":"Takai","year":"2005","journal-title":"J Clin Immunol"},{"key":"B19","doi-asserted-by":"publisher","first-page":"1114","DOI":"10.1002\/1529-0131(200105)44:5<1114::AID-ANR192>3.0.CO;2-B","article-title":"Fc epsilon receptor type I gamma chain replaces the deficient T cell receptor zeta chain in T cells of patients with systemic lupus erythematosus","volume":"44","author":"Enyedy","year":"2001","journal-title":"Arthritis Rheum"},{"key":"B20","doi-asserted-by":"publisher","first-page":"3851","DOI":"10.1182\/blood.V97.12.3851","article-title":"Generation and biochemical analysis of human effector CD4 T cells: alterations in tyrosine phosphorylation and loss of CD3zeta expression","volume":"97","author":"Krishnan","year":"2001","journal-title":"Blood"},{"key":"B21","doi-asserted-by":"publisher","first-page":"4189","DOI":"10.4049\/jimmunol.170.8.4189","article-title":"The FcR gamma subunit and Syk kinase replace the CD3 zeta-chain and ZAP-70 kinase in the TCR signaling complex of human effector CD4 T cells","volume":"170","author":"Krishnan","year":"2003","journal-title":"J Immunol"},{"key":"B22","doi-asserted-by":"publisher","first-page":"2063","DOI":"10.4049\/jimmunol.0803600","article-title":"Activation of mammalian target of rapamycin controls the loss of TCRzeta in lupus T cells through HRES-1\/Rab4-regulated lysosomal degradation","volume":"182","author":"Fernandez","year":"2009","journal-title":"J Immunol"},{"key":"B23","doi-asserted-by":"publisher","first-page":"616","DOI":"10.1073\/pnas.94.2.616","article-title":"Development and function of T cells in T cell antigen receptor\/CD3 zeta knockout mice reconstituted with Fc epsilon RI gamma","volume":"94","author":"Liu","year":"1997","journal-title":"Proc Natl Acad Sci U S A"},{"key":"B24","doi-asserted-by":"publisher","first-page":"1948","DOI":"10.1002\/art.11072","article-title":"Reconstitution of deficient T cell receptor zeta chain restores T cell signaling and augments T cell receptor\/CD3-induced interleukin-2 production in patients with systemic lupus erythematosus","volume":"48","author":"Nambiar","year":"2003","journal-title":"Arthritis Rheum"},{"key":"B25","doi-asserted-by":"publisher","first-page":"3563","DOI":"10.4049\/jimmunol.1300634","article-title":"T cell CD3zeta deficiency enables multiorgan tissue inflammation","volume":"191","author":"Deng","year":"2013","journal-title":"J Immunol"},{"key":"B26","doi-asserted-by":"publisher","first-page":"6048","DOI":"10.4049\/jimmunol.169.10.6048","article-title":"Defective production of functional 98-kDa form of Elf-1 is responsible for the decreased expression of TCR zeta-chain in patients with systemic lupus erythematosus","volume":"169","author":"Juang","year":"2002","journal-title":"J Immunol"},{"key":"B27","doi-asserted-by":"publisher","first-page":"133","DOI":"10.1006\/jaut.2000.0475","article-title":"Polymorphisms\/mutations of TCR-zeta-chain promoter and 3\u2019 untranslated region and selective expression of TCR zeta-chain with an alternatively spliced 3\u2019 untranslated region in patients with systemic lupus erythematosus","volume":"16","author":"Nambiar","year":"2001","journal-title":"J Autoimmun"},{"key":"B28","doi-asserted-by":"publisher","first-page":"2496","DOI":"10.4049\/jimmunol.171.5.2496","article-title":"TCR zeta mRNA with an alternatively spliced 3\u2019-untranslated region detected in systemic lupus erythematosus patients leads to the down-regulation of TCR zeta and TCR\/CD3 complex","volume":"171","author":"Tsuzaka","year":"2003","journal-title":"J Immunol"},{"key":"B29","doi-asserted-by":"publisher","first-page":"3518","DOI":"10.4049\/jimmunol.174.6.3518","article-title":"A splice variant of the TCR zeta mRNA lacking exon 7 leads to the down-regulation of TCR zeta, the TCR\/CD3 complex, and IL-2 production in systemic lupus erythematosus T cells","volume":"174","author":"Tsuzaka","year":"2005","journal-title":"J Immunol"},{"key":"B30","doi-asserted-by":"publisher","first-page":"18959","DOI":"10.1074\/jbc.M501048200","article-title":"Decreased stability and translation of T cell receptor zeta mRNA with an alternatively spliced 3\u2019-untranslated region contribute to zeta chain down-regulation in patients with systemic lupus erythematosus","volume":"280","author":"Chowdhury","year":"2005","journal-title":"J Biol Chem"},{"key":"B31","doi-asserted-by":"publisher","first-page":"20037","DOI":"10.1074\/jbc.M710434200","article-title":"The RNA-stabilizing protein HuR regulates the expression of zeta chain of the human T cell receptor-associated CD3 complex","volume":"283","author":"Moulton","year":"2008","journal-title":"J Biol Chem"},{"key":"B32","doi-asserted-by":"publisher","first-page":"12490","DOI":"10.1074\/jbc.M109.091660","article-title":"Alternative splicing factor\/splicing factor 2 regulates the expression of the zeta subunit of the human T cell receptor-associated CD3 complex","volume":"285","author":"Moulton","year":"2010","journal-title":"J Biol Chem"},{"key":"B33","doi-asserted-by":"publisher","first-page":"e0131073","DOI":"10.1371\/journal.pone.0131073","article-title":"Serine arginine-rich splicing factor 1 (SRSF1) contributes to the transcriptional activation of CD3zeta in human T cells","volume":"10","author":"Moulton","year":"2015","journal-title":"PLoS One"},{"key":"B34","doi-asserted-by":"publisher","first-page":"1845","DOI":"10.1073\/pnas.1214207110","article-title":"Splicing factor SF2\/ASF rescues IL-2 production in T cells from systemic lupus erythematosus patients by activating IL-2 transcription","volume":"110","author":"Moulton","year":"2013","journal-title":"Proc Natl Acad Sci U S A"},{"key":"B35","doi-asserted-by":"publisher","first-page":"467","DOI":"10.1093\/rheumatology\/kew405","article-title":"CD3Z hypermethylation is associated with severe clinical manifestations in systemic lupus erythematosus and reduces CD3zeta-chain expression in T cells","volume":"56","author":"Hong","year":"2017","journal-title":"Rheumatology (Oxford)"},{"key":"B36","doi-asserted-by":"publisher","first-page":"38","DOI":"10.1016\/j.clim.2017.07.012","article-title":"The serine\/threonine protein phosphatase 2A controls autoimmunity","volume":"186","author":"Sharabi","year":"2018","journal-title":"Clin Immunol"},{"key":"B37","doi-asserted-by":"publisher","first-page":"3658","DOI":"10.4049\/jimmunol.181.5.3658","article-title":"PP2A dephosphorylates Elf-1 and determines the expression of CD3zeta and FcRgamma in human systemic lupus erythematosus T cells","volume":"181","author":"Juang","year":"2008","journal-title":"J Immunol"},{"key":"B38","doi-asserted-by":"publisher","first-page":"387","DOI":"10.1006\/jaut.1998.0230","article-title":"Protein tyrosine kinase activity in T lymphocytes from patients with systemic lupus erythematosus","volume":"11","author":"Blasini","year":"1998","journal-title":"J Autoimmun"},{"key":"B39","doi-asserted-by":"publisher","first-page":"111","DOI":"10.3109\/08916939908995380","article-title":"p56lck activity and expression in peripheral blood lymphocytes from patients with systemic lupus erythematosus","volume":"29","author":"Matache","year":"1999","journal-title":"Autoimmunity"},{"key":"B40","doi-asserted-by":"publisher","first-page":"27","DOI":"10.3109\/08916930108994123","article-title":"Dysregulation of p56lck kinase in patients with systemic lupus erythematosus","volume":"34","author":"Matache","year":"2001","journal-title":"Autoimmunity"},{"key":"B41","doi-asserted-by":"publisher","first-page":"1343","DOI":"10.1002\/art.10978","article-title":"Increased ubiquitination and reduced expression of LCK in T lymphocytes from patients with systemic lupus erythematosus","volume":"48","author":"Jury","year":"2003","journal-title":"Arthritis Rheum"},{"key":"B42","doi-asserted-by":"publisher","first-page":"620","DOI":"10.1002\/cphc.200300670","article-title":"Mechanism of Lck recruitment to the T-cell receptor cluster as studied by single-molecule-fluorescence video imaging","volume":"4","author":"Ike","year":"2003","journal-title":"Chemphyschem"},{"key":"B43","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1080\/09687860500453673","article-title":"Lipid rafts in T cell receptor signalling","volume":"23","author":"Kabouridis","year":"2006","journal-title":"Mol Membr Biol"},{"key":"B44","doi-asserted-by":"publisher","first-page":"121","DOI":"10.1083\/jcb.200505047","article-title":"Condensation of the plasma membrane at the site of T lymphocyte activation","volume":"171","author":"Gaus","year":"2005","journal-title":"J Cell Biol"},{"key":"B45","doi-asserted-by":"publisher","first-page":"608","DOI":"10.1016\/j.semcdb.2007.08.002","article-title":"Lipid rafts in T cell signalling and disease","volume":"18","author":"Jury","year":"2007","journal-title":"Semin Cell Dev Biol"},{"key":"B46","doi-asserted-by":"publisher","first-page":"1176","DOI":"10.1172\/JCI200420345","article-title":"Altered lipid raft-associated signaling and ganglioside expression in T lymphocytes from patients with systemic lupus erythematosus","volume":"113","author":"Jury","year":"2004","journal-title":"J Clin Invest"},{"key":"B47","doi-asserted-by":"publisher","first-page":"7821","DOI":"10.4049\/jimmunol.172.12.7821","article-title":"Alterations in lipid raft composition and dynamics contribute to abnormal T cell responses in systemic lupus erythematosus","volume":"172","author":"Krishnan","year":"2004","journal-title":"J Immunol"},{"key":"B48","doi-asserted-by":"publisher","first-page":"1938","DOI":"10.4049\/jimmunol.178.3.1938","article-title":"Phosphorylated ERM is responsible for increased T cell polarization, adhesion, and migration in patients with systemic lupus erythematosus","volume":"178","author":"Li","year":"2007","journal-title":"J Immunol"},{"key":"B49","doi-asserted-by":"publisher","first-page":"7416","DOI":"10.4049\/jimmunol.177.10.7416","article-title":"Atorvastatin restores Lck expression and lipid raft-associated signaling in T cells from patients with systemic lupus erythematosus","volume":"177","author":"Jury","year":"2006","journal-title":"J Immunol"},{"key":"B50","doi-asserted-by":"publisher","first-page":"649","DOI":"10.1016\/0092-8674(92)90598-7","article-title":"ZAP-70: a 70 kd protein-tyrosine kinase that associates with the TCR zeta chain","volume":"71","author":"Chan","year":"1992","journal-title":"Cell"},{"key":"B51","doi-asserted-by":"publisher","first-page":"8145","DOI":"10.4049\/jimmunol.181.11.8145","article-title":"Differential expression and molecular associations of Syk in systemic lupus erythematosus T cells","volume":"181","author":"Krishnan","year":"2008","journal-title":"J Immunol"},{"key":"B52","doi-asserted-by":"publisher","first-page":"103","DOI":"10.1007\/s10067-016-3475-7","article-title":"BLK pathway-associated rs13277113 GA genotype is more frequent in SLE patients and associated with low gene expression and increased flares","volume":"36","author":"Pamuk","year":"2017","journal-title":"Clin Rheumatol"},{"key":"B53","doi-asserted-by":"publisher","first-page":"695","DOI":"10.1177\/0961203314560424","article-title":"Increased Syk phosphorylation leads to overexpression of TRAF6 in peripheral B cells of patients with systemic lupus erythematosus","volume":"24","author":"Iwata","year":"2015","journal-title":"Lupus"},{"key":"B54","doi-asserted-by":"publisher","first-page":"143","DOI":"10.1038\/nbt0208-143","article-title":"Small molecule challenges dominance of TNF-alpha inhibitors","volume":"26","author":"Sheridan","year":"2008","journal-title":"Nat Biotechnol"},{"key":"B55","doi-asserted-by":"publisher","first-page":"1166","DOI":"10.1124\/dmd.110.032151","article-title":"Metabolism of fostamatinib, the oral methylene phosphate prodrug of the spleen tyrosine kinase inhibitor R406 in humans: contribution of hepatic and gut bacterial processes to the overall biotransformation","volume":"38","author":"Sweeny","year":"2010","journal-title":"Drug Metab Dispos"},{"key":"B56","doi-asserted-by":"publisher","first-page":"2086","DOI":"10.1002\/art.27452","article-title":"Suppression of skin and kidney disease by inhibition of spleen tyrosine kinase in lupus-prone mice","volume":"62","author":"Deng","year":"2010","journal-title":"Arthritis Rheum"},{"key":"B57","doi-asserted-by":"publisher","first-page":"1433","DOI":"10.1002\/art.23428","article-title":"An orally bioavailable spleen tyrosine kinase inhibitor delays disease progression and prolongs survival in murine lupus","volume":"58","author":"Bahjat","year":"2008","journal-title":"Arthritis Rheum"},{"key":"B58","doi-asserted-by":"publisher","first-page":"1960","DOI":"10.4049\/jimmunol.178.3.1960","article-title":"Increased levels of NF-ATc2 differentially regulate CD154 and IL-2 genes in T cells from patients with systemic lupus erythematosus","volume":"178","author":"Kyttaris","year":"2007","journal-title":"J Immunol"},{"key":"B59","doi-asserted-by":"publisher","first-page":"876","DOI":"10.1073\/pnas.0810769106","article-title":"CD40-CD40L cross-talk integrates strong antigenic signals and microbial stimuli to induce development of IL-17-producing CD4+ T cells","volume":"106","author":"Iezzi","year":"2009","journal-title":"Proc Natl Acad Sci U S A"},{"key":"B60","doi-asserted-by":"publisher","first-page":"2058","DOI":"10.1002\/art.30353","article-title":"Calcium signaling in systemic lupus erythematosus T cells: a treatment target","volume":"63","author":"Kyttaris","year":"2011","journal-title":"Arthritis Rheum"},{"key":"B61","doi-asserted-by":"publisher","first-page":"1561","DOI":"10.1093\/ndt\/gfw289","article-title":"Pro: the use of calcineurin inhibitors in the treatment of lupus nephritis","volume":"31","author":"Mok","year":"2016","journal-title":"Nephrol Dial Transplant"},{"key":"B62","doi-asserted-by":"publisher","first-page":"182","DOI":"10.3389\/fimmu.2015.00182","article-title":"The role of CD44 in disease pathophysiology and targeted treatment","volume":"6","author":"Jordan","year":"2015","journal-title":"Front Immunol"},{"key":"B63","doi-asserted-by":"publisher","first-page":"295","DOI":"10.1007\/s00251-017-0976-8","article-title":"Novel linkage disequilibrium clustering algorithm identifies new lupus genes on meta-analysis of GWAS datasets","volume":"69","author":"Saeed","year":"2017","journal-title":"Immunogenetics"},{"key":"B64","doi-asserted-by":"publisher","first-page":"1431","DOI":"10.1002\/art.27385","article-title":"Expression of CD44 variant isoforms CD44v3 and CD44v6 is increased on T cells from patients with systemic lupus erythematosus and is correlated with disease activity","volume":"62","author":"Crispin","year":"2010","journal-title":"Arthritis Rheum"},{"key":"B65","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1093\/intimm\/12.1.37","article-title":"The CD44 variant isoforms CD44v6 and CD44v7 are expressed by distinct leukocyte subpopulations and exert non-overlapping functional activities","volume":"12","author":"Seiter","year":"2000","journal-title":"Int Immunol"},{"key":"B66","doi-asserted-by":"publisher","first-page":"600","DOI":"10.1002\/1521-4141(200102)31:2<600::AID-IMMU600>3.0.CO;2-8","article-title":"Constitutive intracellular expression and activation-induced cell surface up-regulation of CD44v3 in human T lymphocytes","volume":"31","author":"Forster-Horvath","year":"2001","journal-title":"Eur J Immunol"},{"key":"B67","doi-asserted-by":"publisher","first-page":"29602","DOI":"10.1074\/jbc.M803606200","article-title":"Structural basis for CD44 recognition by ERM proteins","volume":"283","author":"Mori","year":"2008","journal-title":"J Biol Chem"},{"key":"B68","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1016\/S0014-5793(98)01674-3","article-title":"Moesin, the major ERM protein of lymphocytes and platelets, differs from ezrin in its insensitivity to calpain","volume":"443","author":"Shcherbina","year":"1999","journal-title":"FEBS Lett"},{"key":"B69","doi-asserted-by":"publisher","first-page":"705","DOI":"10.1093\/intimm\/dxs077","article-title":"Moesin-deficient mice reveal a non-redundant role for moesin in lymphocyte homeostasis","volume":"24","author":"Hirata","year":"2012","journal-title":"Int Immunol"},{"key":"B70","doi-asserted-by":"publisher","first-page":"3418","DOI":"10.4049\/jimmunol.1700074","article-title":"The ERM protein moesin regulates CD8(+) regulatory T cell homeostasis and self-tolerance","volume":"199","author":"Satooka","year":"2017","journal-title":"J Immunol"},{"key":"B71","doi-asserted-by":"publisher","first-page":"355","DOI":"10.1146\/annurev-med-051914-022120","article-title":"Rho kinases in autoimmune diseases","volume":"67","author":"Pernis","year":"2016","journal-title":"Annu Rev Med"},{"key":"B72","doi-asserted-by":"publisher","first-page":"545","DOI":"10.1002\/cm.20472","article-title":"Rho-kinase\/ROCK: a key regulator of the cytoskeleton and cell polarity","volume":"67","author":"Amano","year":"2010","journal-title":"Cytoskeleton (Hoboken)"},{"key":"B73","doi-asserted-by":"publisher","first-page":"174","DOI":"10.4161\/sgtp.1.3.14724","article-title":"Multiple roles for RhoA during T cell transendothelial migration","volume":"1","author":"Heasman","year":"2010","journal-title":"Small GTPases"},{"key":"B74","doi-asserted-by":"publisher","first-page":"1010","DOI":"10.1038\/s41467-017-01032-2","article-title":"ROCK regulates the intermittent mode of interstitial T cell migration in inflamed lungs","volume":"8","author":"Mrass","year":"2017","journal-title":"Nat Commun"},{"key":"B75","doi-asserted-by":"publisher","first-page":"3280","DOI":"10.1172\/JCI42856","article-title":"Phosphorylation of IRF4 by ROCK2 regulates IL-17 and IL-21 production and the development of autoimmunity in mice","volume":"120","author":"Biswas","year":"2010","journal-title":"J Clin Invest"},{"key":"B76","doi-asserted-by":"publisher","first-page":"16814","DOI":"10.1073\/pnas.1414189111","article-title":"Selective oral ROCK2 inhibitor down-regulates IL-21 and IL-17 secretion in human T cells via STAT3-dependent mechanism","volume":"111","author":"Zanin-Zhorov","year":"2014","journal-title":"Proc Natl Acad Sci U S A"},{"key":"B77","doi-asserted-by":"publisher","first-page":"ra73","DOI":"10.1126\/scisignal.aad8953","article-title":"ROCK2 signaling is required to induce a subset of T follicular helper cells through opposing effects on STATs in autoimmune settings","volume":"9","author":"Weiss","year":"2016","journal-title":"Sci Signal"},{"key":"B78","doi-asserted-by":"publisher","first-page":"1592","DOI":"10.1002\/art.37934","article-title":"Enhanced rho-associated protein kinase activation in patients with systemic lupus erythematosus","volume":"65","author":"Isgro","year":"2013","journal-title":"Arthritis Rheum"},{"key":"B79","doi-asserted-by":"publisher","first-page":"740","DOI":"10.1136\/annrheumdis-2016-209850","article-title":"Targeting the RhoA-ROCK pathway to reverse T-cell dysfunction in SLE","volume":"76","author":"Rozo","year":"2017","journal-title":"Ann Rheum Dis"},{"key":"B80","doi-asserted-by":"publisher","first-page":"2","DOI":"10.1002\/acn3.19","article-title":"Selective ROCK2 inhibition in focal cerebral ischemia","volume":"1","author":"Lee","year":"2014","journal-title":"Ann Clin Transl Neurol"},{"key":"B81","doi-asserted-by":"publisher","first-page":"990","DOI":"10.1038\/40187","article-title":"Calcium sensitization of smooth muscle mediated by a Rho-associated protein kinase in hypertension","volume":"389","author":"Uehata","year":"1997","journal-title":"Nature"},{"key":"B82","doi-asserted-by":"publisher","first-page":"1654","DOI":"10.1634\/stemcells.2006-0753","article-title":"Simvastatin suppresses self-renewal of mouse embryonic stem cells by inhibiting RhoA geranylgeranylation","volume":"25","author":"Lee","year":"2007","journal-title":"Stem Cells"},{"key":"B83","doi-asserted-by":"publisher","first-page":"359","DOI":"10.1016\/j.biopha.2017.01.069","article-title":"Y-27632, a Rho-associated protein kinase inhibitor, inhibits systemic lupus erythematosus","volume":"88","author":"Wang","year":"2017","journal-title":"Biomed Pharmacother"},{"key":"B84","doi-asserted-by":"publisher","first-page":"2269","DOI":"10.1021\/acs.jmedchem.5b00683","article-title":"Rho kinase (ROCK) inhibitors and their therapeutic potential","volume":"59","author":"Feng","year":"2016","journal-title":"J Med Chem"},{"key":"B85","doi-asserted-by":"publisher","first-page":"656","DOI":"10.1177\/0961203312436862","article-title":"Administration of fasudil, a ROCK inhibitor, attenuates disease in lupus-prone NZB\/W F1 female mice","volume":"21","author":"Stirzaker","year":"2012","journal-title":"Lupus"},{"key":"B86","doi-asserted-by":"publisher","first-page":"194","DOI":"10.1016\/j.tibs.2005.02.008","article-title":"Signalling by PI3K isoforms: insights from gene-targeted mice","volume":"30","author":"Vanhaesebroeck","year":"2005","journal-title":"Trends Biochem Sci"},{"key":"B87","doi-asserted-by":"publisher","first-page":"253","DOI":"10.1111\/j.1600-065X.2008.00750.x","article-title":"Fine tuning the immune response with PI3K","volume":"228","author":"Fruman","year":"2009","journal-title":"Immunol Rev"},{"key":"B88","doi-asserted-by":"publisher","first-page":"245","DOI":"10.3389\/fimmu.2012.00245","article-title":"The role of the PI3K signaling pathway in CD4(+) T cell differentiation and function","volume":"3","author":"Han","year":"2012","journal-title":"Front Immunol"},{"key":"B89","doi-asserted-by":"publisher","first-page":"465","DOI":"10.1042\/BJ20112092","article-title":"PI3K signalling in B- and T-lymphocytes: new developments and therapeutic advances","volume":"442","author":"So","year":"2012","journal-title":"Biochem J"},{"key":"B90","doi-asserted-by":"publisher","first-page":"1040","DOI":"10.1126\/science.287.5455.1040","article-title":"Function of PI3Kgamma in thymocyte development, T cell activation, and neutrophil migration","volume":"287","author":"Sasaki","year":"2000","journal-title":"Science"},{"key":"B91","doi-asserted-by":"publisher","first-page":"589","DOI":"10.4049\/jimmunol.176.1.589","article-title":"Class IB-phosphatidylinositol 3-kinase (PI3K) deficiency ameliorates IA-PI3K-induced systemic lupus but not T cell invasion","volume":"176","author":"Barber","year":"2006","journal-title":"J Immunol"},{"key":"B92","doi-asserted-by":"publisher","first-page":"649","DOI":"10.1038\/nri3278","article-title":"FOXO transcription factors throughout T cell biology","volume":"12","author":"Hedrick","year":"2012","journal-title":"Nat Rev Immunol"},{"key":"B93","doi-asserted-by":"publisher","first-page":"895","DOI":"10.1096\/fasebj.14.7.895","article-title":"Increased phosphoinositide 3-kinase activity induces a lymphoproliferative disorder and contributes to tumor generation in vivo","volume":"14","author":"Borlado","year":"2000","journal-title":"FASEB J"},{"key":"B94","doi-asserted-by":"publisher","first-page":"e1001090","DOI":"10.1371\/journal.pbio.1001090","article-title":"The naturally processed CD95L elicits a c-yes\/calcium\/PI3K-driven cell migration pathway","volume":"9","author":"Tauzin","year":"2011","journal-title":"PLoS Biol"},{"key":"B95","doi-asserted-by":"publisher","first-page":"933","DOI":"10.1038\/nm1291","article-title":"PI3Kgamma inhibition blocks glomerulonephritis and extends lifespan in a mouse model of systemic lupus","volume":"11","author":"Barber","year":"2005","journal-title":"Nat Med"},{"key":"B96","doi-asserted-by":"publisher","first-page":"2376","DOI":"10.4049\/jimmunol.1101602","article-title":"Enhanced phosphoinositide 3-kinase delta activity is a frequent event in systemic lupus erythematosus that confers resistance to activation-induced T cell death","volume":"187","author":"Suarez-Fueyo","year":"2011","journal-title":"J Immunol"},{"key":"B97","doi-asserted-by":"publisher","first-page":"544","DOI":"10.4049\/jimmunol.1400350","article-title":"Inhibition of PI3Kdelta reduces kidney infiltration by macrophages and ameliorates systemic lupus in the mouse","volume":"193","author":"Suarez-Fueyo","year":"2014","journal-title":"J Immunol"},{"key":"B98","doi-asserted-by":"publisher","first-page":"2088","DOI":"10.1126\/science.1068094","article-title":"Living with lethal PIP3 levels: viability of flies lacking PTEN restored by a PH domain mutation in Akt\/PKB","volume":"295","author":"Stocker","year":"2002","journal-title":"Science"},{"key":"B99","first-page":"2124","article-title":"TEP1, encoded by a candidate tumor suppressor locus, is a novel protein tyrosine phosphatase regulated by transforming growth factor beta","volume":"57","author":"Li","year":"1997","journal-title":"Cancer Res"},{"key":"B100","doi-asserted-by":"publisher","first-page":"1943","DOI":"10.1126\/science.275.5308.1943","article-title":"PTEN, a putative protein tyrosine phosphatase gene mutated in human brain, breast, and prostate cancer","volume":"275","author":"Li","year":"1997","journal-title":"Science"},{"key":"B101","doi-asserted-by":"publisher","first-page":"356","DOI":"10.1038\/ng0497-356","article-title":"Identification of a candidate tumour suppressor gene, MMAC1, at chromosome 10q23.3 that is mutated in multiple advanced cancers","volume":"15","author":"Steck","year":"1997","journal-title":"Nat Genet"},{"key":"B102","doi-asserted-by":"publisher","first-page":"523","DOI":"10.1016\/S1074-7613(01)00134-0","article-title":"T cell-specific loss of Pten leads to defects in central and peripheral tolerance","volume":"14","author":"Suzuki","year":"2001","journal-title":"Immunity"},{"key":"B103","doi-asserted-by":"publisher","first-page":"239","DOI":"10.1111\/j.1600-065X.2008.00650.x","article-title":"Regulation of T-cell responses by PTEN","volume":"224","author":"Buckler","year":"2008","journal-title":"Immunol Rev"},{"key":"B104","doi-asserted-by":"publisher","first-page":"188","DOI":"10.1038\/ni.3077","article-title":"Control of PI(3) kinase in Treg cells maintains homeostasis and lineage stability","volume":"16","author":"Huynh","year":"2015","journal-title":"Nat Immunol"},{"key":"B105","doi-asserted-by":"publisher","first-page":"178","DOI":"10.1038\/ni.3076","article-title":"Treg cells require the phosphatase PTEN to restrain TH1 and TFH cell responses","volume":"16","author":"Shrestha","year":"2015","journal-title":"Nat Immunol"},{"key":"B106","doi-asserted-by":"publisher","first-page":"34617","DOI":"10.1038\/srep34617","article-title":"PTEN ameliorates autoimmune arthritis through down-regulating STAT3 activation with reciprocal balance of Th17 and Tregs","volume":"6","author":"Lee","year":"2016","journal-title":"Sci Rep"},{"key":"B107","doi-asserted-by":"publisher","first-page":"3381","DOI":"10.1084\/jem.20170523","article-title":"PTEN drives Th17\u2009cell differentiation by preventing IL-2 production","volume":"214","author":"Kim","year":"2017","journal-title":"J Exp Med"},{"key":"B108","doi-asserted-by":"publisher","first-page":"C470","DOI":"10.1152\/ajpcell.00129.2015","article-title":"miR-148a-3p overexpression contributes to glomerular cell proliferation by targeting PTEN in lupus nephritis","volume":"310","author":"Qingjuan","year":"2016","journal-title":"Am J Physiol Cell Physiol"},{"key":"B109","doi-asserted-by":"publisher","first-page":"246ra299","DOI":"10.1126\/scitranslmed.3009131","article-title":"Defective PTEN regulation contributes to B cell hyperresponsiveness in systemic lupus erythematosus","volume":"6","author":"Wu","year":"2014","journal-title":"Sci Transl Med"},{"key":"B110","doi-asserted-by":"publisher","first-page":"487","DOI":"10.1016\/j.devcel.2007.03.020","article-title":"The two TORCs and Akt","volume":"12","author":"Bhaskar","year":"2007","journal-title":"Dev Cell"},{"key":"B111","doi-asserted-by":"publisher","first-page":"169","DOI":"10.1038\/nrrheum.2015.172","article-title":"Activation of mTOR (mechanistic target of rapamycin) in rheumatic diseases","volume":"12","author":"Perl","year":"2016","journal-title":"Nat Rev Rheumatol"},{"key":"B112","doi-asserted-by":"publisher","first-page":"960","DOI":"10.1016\/j.cell.2017.02.004","article-title":"mTOR signaling in growth, metabolism, and disease","volume":"168","author":"Saxton","year":"2017","journal-title":"Cell"},{"key":"B113","doi-asserted-by":"publisher","first-page":"2259","DOI":"10.1002\/art.40223","article-title":"Review: metabolic control of immune system activation in rheumatic diseases","volume":"69","author":"Perl","year":"2017","journal-title":"Arthritis Rheumatol"},{"key":"B114","doi-asserted-by":"publisher","first-page":"1037","DOI":"10.1101\/gad.1529107","article-title":"The transcription factor HIF-1alpha plays a critical role in the growth factor-dependent regulation of both aerobic and anaerobic glycolysis","volume":"21","author":"Lum","year":"2007","journal-title":"Genes Dev"},{"key":"B115","doi-asserted-by":"publisher","first-page":"274ra218","DOI":"10.1126\/scitranslmed.aaa0835","article-title":"Normalization of CD4+ T cell metabolism reverses lupus","volume":"7","author":"Yin","year":"2015","journal-title":"Sci Transl Med"},{"key":"B116","doi-asserted-by":"publisher","first-page":"80","DOI":"10.4049\/jimmunol.1501537","article-title":"Glucose oxidation is critical for CD4+ T cell activation in a mouse model of systemic lupus erythematosus","volume":"196","author":"Yin","year":"2016","journal-title":"J Immunol"},{"key":"B117","doi-asserted-by":"publisher","first-page":"280","DOI":"10.1038\/nrrheum.2017.43","article-title":"Immunometabolism in systemic lupus erythematosus","volume":"13","author":"Morel","year":"2017","journal-title":"Nat Rev Rheumatol"},{"key":"B118","doi-asserted-by":"publisher","first-page":"175","DOI":"10.1002\/1529-0131(200201)46:1<175::AID-ART10015>3.0.CO;2-H","article-title":"Mitochondrial hyperpolarization and ATP depletion in patients with systemic lupus erythematosus","volume":"46","author":"Gergely","year":"2002","journal-title":"Arthritis Rheum"},{"key":"B119","doi-asserted-by":"publisher","first-page":"73","DOI":"10.1007\/s11926-016-0622-8","article-title":"Activation of the mechanistic target of rapamycin in SLE: explosion of evidence in the last five years","volume":"18","author":"Oaks","year":"2016","journal-title":"Curr Rheumatol Rep"},{"key":"B120","doi-asserted-by":"publisher","first-page":"295","DOI":"10.1038\/ni.2005","article-title":"The kinase mTOR regulates the differentiation of helper T cells through the selective activation of signaling by mTORC1 and mTORC2","volume":"12","author":"Delgoffe","year":"2011","journal-title":"Nat Immunol"},{"key":"B121","doi-asserted-by":"publisher","first-page":"e0154564","DOI":"10.1371\/journal.pone.0154564","article-title":"mTOR inhibition attenuates dextran sulfate sodium-induced colitis by suppressing T cell proliferation and balancing TH1\/TH17\/Treg profile","volume":"11","author":"Hu","year":"2016","journal-title":"PLoS One"},{"key":"B122","doi-asserted-by":"publisher","first-page":"540","DOI":"10.1016\/j.immuni.2016.08.017","article-title":"mTORC1 and mTORC2 kinase signaling and glucose metabolism drive follicular helper T cell differentiation","volume":"45","author":"Zeng","year":"2016","journal-title":"Immunity"},{"key":"B123","doi-asserted-by":"publisher","first-page":"485","DOI":"10.1038\/nature12297","article-title":"mTORC1 couples immune signals and metabolic programming to establish T(reg)-cell function","volume":"499","author":"Zeng","year":"2013","journal-title":"Nature"},{"key":"B124","doi-asserted-by":"publisher","first-page":"832","DOI":"10.1016\/j.immuni.2009.04.014","article-title":"The mTOR kinase differentially regulates effector and regulatory T cell lineage commitment","volume":"30","author":"Delgoffe","year":"2009","journal-title":"Immunity"},{"key":"B125","doi-asserted-by":"publisher","first-page":"556","DOI":"10.1038\/ni.3390","article-title":"Phosphatase PP2A is requisite for the function of regulatory T cells","volume":"17","author":"Apostolidis","year":"2016","journal-title":"Nat Immunol"},{"key":"B126","doi-asserted-by":"publisher","first-page":"2728","DOI":"10.1002\/art.39791","article-title":"Mitochondrial dysfunction in the liver and antiphospholipid antibody production precede disease onset and respond to rapamycin in lupus-prone mice","volume":"68","author":"Oaks","year":"2016","journal-title":"Arthritis Rheumatol"},{"key":"B127","doi-asserted-by":"publisher","first-page":"4134","DOI":"10.4049\/jimmunol.1301859","article-title":"Mechanistic target of rapamycin complex 1 expands Th17 and IL-4+ CD4-CD8- double-negative T cells and contracts regulatory T cells in systemic lupus erythematosus","volume":"192","author":"Kato","year":"2014","journal-title":"J Immunol"},{"key":"B128","doi-asserted-by":"publisher","first-page":"16035","DOI":"10.1038\/nrdp.2016.35","article-title":"Tuberous sclerosis complex","volume":"2","author":"Henske","year":"2016","journal-title":"Nat Rev Dis Primers"},{"key":"B129","doi-asserted-by":"publisher","first-page":"134","DOI":"10.1097\/RHU.0b013e318289c033","article-title":"Tuberous sclerosis and fulminant lupus in a young woman","volume":"19","author":"Singh","year":"2013","journal-title":"J Clin Rheumatol"},{"key":"B130","doi-asserted-by":"publisher","first-page":"2234","DOI":"10.1172\/JCI73411","article-title":"CaMK4-dependent activation of AKT\/mTOR and CREM-alpha underlies autoimmunity-associated Th17 imbalance","volume":"124","author":"Koga","year":"2014","journal-title":"J Clin Invest"},{"key":"B131","doi-asserted-by":"publisher","first-page":"427","DOI":"10.1002\/art.40380","article-title":"The IL-21-mTOR axis blocks treg differentiation and function by suppression of autophagy in patients with systemic lupus erythematosus","volume":"70","author":"Kato","year":"2018","journal-title":"Arthritis Rheumatol"},{"key":"B132","doi-asserted-by":"publisher","first-page":"4895","DOI":"10.4049\/jimmunol.1400044","article-title":"Akt-dependent enhanced migratory capacity of Th17\u2009cells from children with lupus nephritis","volume":"193","author":"Kshirsagar","year":"2014","journal-title":"J Immunol"},{"key":"B133","doi-asserted-by":"publisher","first-page":"1102","DOI":"10.18632\/aging.100925","article-title":"Rapamycin reverses the senescent phenotype and improves immunoregulation of mesenchymal stem cells from MRL\/lpr mice and systemic lupus erythematosus patients through inhibition of the mTOR signaling pathway","volume":"8","author":"Gu","year":"2016","journal-title":"Aging (Albany NY)"},{"key":"B134","doi-asserted-by":"publisher","first-page":"2983","DOI":"10.1002\/art.22085","article-title":"Rapamycin reduces disease activity and normalizes T cell activation-induced calcium fluxing in patients with systemic lupus erythematosus","volume":"54","author":"Fernandez","year":"2006","journal-title":"Arthritis Rheum"},{"key":"B135","doi-asserted-by":"publisher","first-page":"2937","DOI":"10.1002\/art.34502","article-title":"N-acetylcysteine reduces disease activity by blocking mammalian target of rapamycin in T cells from systemic lupus erythematosus patients: a randomized, double-blind, placebo-controlled trial","volume":"64","author":"Lai","year":"2012","journal-title":"Arthritis Rheum"},{"key":"B136","doi-asserted-by":"publisher","first-page":"483","DOI":"10.1111\/j.1365-2710.2009.01108.x","article-title":"The effect of high dose of N-acetylcysteine in lupus nephritis: a case report and literature review","volume":"35","author":"Tewthanom","year":"2010","journal-title":"J Clin Pharm Ther"},{"key":"B137","doi-asserted-by":"publisher","first-page":"689","DOI":"10.3892\/etm.2015.2510","article-title":"Early-stage lupus nephritis treated with N-acetylcysteine: a report of two cases","volume":"10","author":"Li","year":"2015","journal-title":"Exp Ther Med"},{"key":"B138","doi-asserted-by":"publisher","first-page":"1186","DOI":"10.1016\/S0140-6736(18)30485-9","article-title":"Sirolimus in patients with clinically active systemic lupus erythematosus resistant to, or intolerant of, conventional medications: a single-arm, open-label, phase 1\/2 trial","volume":"391","author":"Lai","year":"2018","journal-title":"Lancet"},{"key":"B139","doi-asserted-by":"publisher","first-page":"311","DOI":"10.1146\/annurev-med-051113-024537","article-title":"The JAK-STAT pathway: impact on human disease and therapeutic intervention","volume":"66","author":"O\u2019Shea","year":"2015","journal-title":"Annu Rev Med"},{"key":"B140","doi-asserted-by":"publisher","first-page":"125","DOI":"10.1007\/82_2014_372","article-title":"Transcriptional regulatory networks for CD4 T cell differentiation","volume":"381","author":"Christie","year":"2014","journal-title":"Curr Top Microbiol Immunol"},{"key":"B141","doi-asserted-by":"publisher","first-page":"981","DOI":"10.1016\/j.cell.2012.09.044","article-title":"STATs shape the active enhancer landscape of T cell populations","volume":"151","author":"Vahedi","year":"2012","journal-title":"Cell"},{"key":"B142","doi-asserted-by":"publisher","first-page":"164","DOI":"10.1007\/s12016-016-8550-y","article-title":"The role of STAT signaling pathways in the pathogenesis of systemic lupus erythematosus","volume":"52","author":"Goropevsek","year":"2017","journal-title":"Clin Rev Allergy Immunol"},{"key":"B143","doi-asserted-by":"publisher","first-page":"550","DOI":"10.3389\/fimmu.2015.00550","article-title":"Pathogenic inflammation and its therapeutic targeting in systemic lupus erythematosus","volume":"6","author":"Gottschalk","year":"2015","journal-title":"Front Immunol"},{"key":"B144","doi-asserted-by":"publisher","first-page":"415","DOI":"10.1016\/j.berh.2017.10.003","article-title":"Role of interferons in SLE","volume":"31","author":"Bengtsson","year":"2017","journal-title":"Best Pract Res Clin Rheumatol"},{"key":"B145","doi-asserted-by":"publisher","first-page":"717","DOI":"10.1089\/1079990042722882","article-title":"An essential role for IFN-alpha in the overexpression of Fas ligand on MRL\/lpr lymphocytes and on their spontaneous Fas-mediated cytotoxic potential","volume":"24","author":"Hadj-Slimane","year":"2004","journal-title":"J Interferon Cytokine Res"},{"key":"B146","doi-asserted-by":"publisher","first-page":"101","DOI":"10.1177\/0961203306075383","article-title":"Activation of the STAT1 signalling pathway in lupus nephritis in MRL\/lpr mice","volume":"16","author":"Dong","year":"2007","journal-title":"Lupus"},{"key":"B147","doi-asserted-by":"publisher","first-page":"1463","DOI":"10.1002\/art.24449","article-title":"Activation of the interferon-gamma signaling pathway in systemic lupus erythematosus peripheral blood mononuclear cells","volume":"60","author":"Karonitsch","year":"2009","journal-title":"Arthritis Rheum"},{"key":"B148","doi-asserted-by":"publisher","first-page":"R20","DOI":"10.1186\/ar4448","article-title":"Elevated signal transducers and activators of transcription 1 correlates with increased C-C motif chemokine ligand 2 and C-X-C motif chemokine 10 levels in peripheral blood of patients with systemic lupus erythematosus","volume":"16","author":"Dominguez-Gutierrez","year":"2014","journal-title":"Arthritis Res Ther"},{"key":"B149","doi-asserted-by":"publisher","first-page":"171","DOI":"10.1007\/s10875-013-9973-3","article-title":"Positive correlation of STAT1 and miR-146a with anemia in patients with systemic lupus erythematosus","volume":"34","author":"Dominguez-Gutierrez","year":"2014","journal-title":"J Clin Immunol"},{"key":"B150","doi-asserted-by":"publisher","first-page":"91","DOI":"10.1111\/j.1365-2249.2012.04676.x","article-title":"Decreased microRNA(miR)-145 and increased miR-224 expression in T cells from patients with systemic lupus erythematosus involved in lupus immunopathogenesis","volume":"171","author":"Lu","year":"2013","journal-title":"Clin Exp Immunol"},{"key":"B151","doi-asserted-by":"publisher","first-page":"254","DOI":"10.1089\/jir.2016.0040","article-title":"Increased levels of STAT1 protein in blood CD4 T cells from systemic lupus erythematosus patients are associated with perturbed homeostasis of activated CD45RA(-)FOXP3(hi) regulatory subset and follow-up disease severity","volume":"37","author":"Goropevsek","year":"2017","journal-title":"J Interferon Cytokine Res"},{"key":"B152","doi-asserted-by":"publisher","first-page":"1233","DOI":"10.1002\/art.39535","article-title":"Development of Th17-associated interstitial kidney inflammation in lupus-prone mice lacking the gene encoding STAT-1","volume":"68","author":"Yiu","year":"2016","journal-title":"Arthritis Rheumatol"},{"key":"B153","doi-asserted-by":"publisher","first-page":"767","DOI":"10.1007\/s10875-013-9878-1","article-title":"Th22, but not Th17 might be a good index to predict the tissue involvement of systemic lupus erythematosus","volume":"33","author":"Yang","year":"2013","journal-title":"J Clin Immunol"},{"key":"B154","doi-asserted-by":"publisher","first-page":"207","DOI":"10.1016\/j.cyto.2015.01.003","article-title":"Update on the role of Interleukin 17 in rheumatologic autoimmune diseases","volume":"75","author":"Konya","year":"2015","journal-title":"Cytokine"},{"key":"B155","doi-asserted-by":"publisher","first-page":"95","DOI":"10.1016\/j.clim.2016.04.010","article-title":"T cells and IL-17 in lupus nephritis","volume":"185","author":"Koga","year":"2017","journal-title":"Clin Immunol"},{"key":"B156","doi-asserted-by":"publisher","first-page":"8761","DOI":"10.4049\/jimmunol.181.12.8761","article-title":"Expanded double negative T cells in patients with systemic lupus erythematosus produce IL-17 and infiltrate the kidneys","volume":"181","author":"Crispin","year":"2008","journal-title":"J Immunol"},{"key":"B157","doi-asserted-by":"publisher","first-page":"3160","DOI":"10.4049\/jimmunol.0900385","article-title":"The role of IL-23\/IL-17 axis in lupus nephritis","volume":"183","author":"Zhang","year":"2009","journal-title":"J Immunol"},{"key":"B158","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1186\/s12865-015-0070-7","article-title":"IL-17 and IL-23 in lupus nephritis \u2013 association to histopathology and response to treatment","volume":"16","author":"Zickert","year":"2015","journal-title":"BMC Immunol"},{"key":"B159","doi-asserted-by":"publisher","first-page":"715","DOI":"10.1016\/S1074-7613(00)00070-4","article-title":"Novel p19 protein engages IL-12p40 to form a cytokine, IL-23, with biological activities similar as well as distinct from IL-12","volume":"13","author":"Oppmann","year":"2000","journal-title":"Immunity"},{"key":"B160","doi-asserted-by":"publisher","first-page":"5699","DOI":"10.4049\/jimmunol.168.11.5699","article-title":"A receptor for the heterodimeric cytokine IL-23 is composed of IL-12Rbeta1 and a novel cytokine receptor subunit, IL-23R","volume":"168","author":"Parham","year":"2002","journal-title":"J Immunol"},{"key":"B161","doi-asserted-by":"publisher","first-page":"5948","DOI":"10.4049\/jimmunol.181.9.5948","article-title":"IL-23 promotes maintenance but not commitment to the Th17 lineage","volume":"181","author":"Stritesky","year":"2008","journal-title":"J Immunol"},{"key":"B162","doi-asserted-by":"publisher","first-page":"8137","DOI":"10.1073\/pnas.0600666103","article-title":"Selective regulatory function of Socs3 in the formation of IL-17-secreting T cells","volume":"103","author":"Chen","year":"2006","journal-title":"Proc Natl Acad Sci U S A"},{"key":"B163","doi-asserted-by":"publisher","first-page":"9358","DOI":"10.1074\/jbc.C600321200","article-title":"STAT3 regulates cytokine-mediated generation of inflammatory helper T cells","volume":"282","author":"Yang","year":"2007","journal-title":"J Biol Chem"},{"key":"B164","doi-asserted-by":"publisher","first-page":"e13351","DOI":"10.1371\/journal.pone.0013351","article-title":"Gene network analysis of bone marrow mononuclear cells reveals activation of multiple kinase pathways in human systemic lupus erythematosus","volume":"5","author":"Nakou","year":"2010","journal-title":"PLoS One"},{"key":"B165","doi-asserted-by":"publisher","first-page":"3038514","DOI":"10.1155\/2017\/3038514","article-title":"Anti-OSM antibody inhibits tubulointerstitial lesion in a murine model of lupus nephritis","volume":"2017","author":"Liu","year":"2017","journal-title":"Mediators Inflamm"},{"key":"B166","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1080\/08916930601095148","article-title":"Increased expression of STAT3 in SLE T cells contributes to enhanced chemokine-mediated cell migration","volume":"40","author":"Harada","year":"2007","journal-title":"Autoimmunity"},{"key":"B167","doi-asserted-by":"publisher","first-page":"13457","DOI":"10.1073\/pnas.1408023111","article-title":"Stat3 promotes IL-10 expression in lupus T cells through trans-activation and chromatin remodeling","volume":"111","author":"Hedrich","year":"2014","journal-title":"Proc Natl Acad Sci U S A"},{"key":"B168","doi-asserted-by":"publisher","first-page":"3997","DOI":"10.1182\/blood-2011-11-392985","article-title":"Functional STAT3 deficiency compromises the generation of human T follicular helper cells","volume":"119","author":"Ma","year":"2012","journal-title":"Blood"},{"key":"B169","doi-asserted-by":"publisher","first-page":"142","DOI":"10.1038\/ni.3054","article-title":"Pathophysiology of T follicular helper cells in humans and mice","volume":"16","author":"Ueno","year":"2015","journal-title":"Nat Immunol"},{"key":"B170","doi-asserted-by":"publisher","first-page":"935","DOI":"10.1093\/rheumatology\/keg255","article-title":"Cytokine balance in kidney tissue from lupus nephritis patients","volume":"42","author":"Uhm","year":"2003","journal-title":"Rheumatology (Oxford)"},{"key":"B171","doi-asserted-by":"publisher","first-page":"261","DOI":"10.1002\/cyto.b.20468","article-title":"Monocytes and T lymphocytes contribute to a predominance of interleukin 6 and interleukin 10 in systemic lupus erythematosus","volume":"76","author":"Mellor-Pita","year":"2009","journal-title":"Cytometry B Clin Cytom"},{"key":"B172","doi-asserted-by":"publisher","first-page":"931018","DOI":"10.1155\/2010\/931018","article-title":"Hypomethylation of IL10 and IL13 promoters in CD4+ T cells of patients with systemic lupus erythematosus","volume":"2010","author":"Zhao","year":"2010","journal-title":"J Biomed Biotechnol"},{"key":"B173","doi-asserted-by":"publisher","first-page":"221","DOI":"10.1016\/j.clim.2015.04.004","article-title":"Signal transducer and activator of transcription (STAT) 3 inhibition delays the onset of lupus nephritis in MRL\/lpr mice","volume":"158","author":"Edwards","year":"2015","journal-title":"Clin Immunol"},{"key":"B174","doi-asserted-by":"publisher","first-page":"1630","DOI":"10.4049\/jimmunol.174.3.1630","article-title":"Sle1ab mediates the aberrant activation of STAT3 and Ras-ERK signaling pathways in B lymphocytes","volume":"174","author":"Liu","year":"2005","journal-title":"J Immunol"},{"key":"B175","doi-asserted-by":"publisher","first-page":"134","DOI":"10.1186\/s13075-016-1034-x","article-title":"JAK3-STAT pathway blocking benefits in experimental lupus nephritis","volume":"18","author":"Ripoll","year":"2016","journal-title":"Arthritis Res Ther"},{"key":"B176","doi-asserted-by":"publisher","first-page":"148","DOI":"10.1002\/art.39818","article-title":"Tofacitinib ameliorates murine lupus and its associated vascular dysfunction","volume":"69","author":"Furumoto","year":"2017","journal-title":"Arthritis Rheumatol"},{"key":"B177","doi-asserted-by":"publisher","first-page":"697","DOI":"10.1007\/s40265-017-0723-3","article-title":"Baricitinib: first global approval","volume":"77","author":"Markham","year":"2017","journal-title":"Drugs"},{"key":"B178","doi-asserted-by":"publisher","first-page":"2473","DOI":"10.1084\/jem.20061099","article-title":"Interleukin-23 drives innate and T cell-mediated intestinal inflammation","volume":"203","author":"Hue","year":"2006","journal-title":"J Exp Med"},{"key":"B179","doi-asserted-by":"publisher","first-page":"559","DOI":"10.1016\/j.immuni.2008.02.019","article-title":"Interleukin-23 restrains regulatory T cell activity to drive T cell-dependent colitis","volume":"28","author":"Izcue","year":"2008","journal-title":"Immunity"},{"key":"B180","doi-asserted-by":"publisher","first-page":"4605","DOI":"10.4049\/jimmunol.0903595","article-title":"Cutting edge: IL-23 receptor deficiency prevents the development of lupus nephritis in C57BL\/6-lpr\/lpr mice","volume":"184","author":"Kyttaris","year":"2010","journal-title":"J Immunol"},{"key":"B181","doi-asserted-by":"publisher","first-page":"903","DOI":"10.4049\/jimmunol.1700418","article-title":"IL-23 limits the production of IL-2 and promotes autoimmunity in lupus","volume":"199","author":"Dai","year":"2017","journal-title":"J Immunol"},{"key":"B182","doi-asserted-by":"publisher","first-page":"937","DOI":"10.1016\/j.humimm.2016.06.007","article-title":"Effect of IL6 and IL23 on double negative T cells and anti ds-DNA in systemic lupus erythematosus patients","volume":"77","author":"Shaltout","year":"2016","journal-title":"Hum Immunol"},{"key":"B183","first-page":"suppl 10","article-title":"Efficacy and safety of ustekinumab, an interleukin 12\/23 inhibitor, in patients with active systemic lupus erythematosus: results of a phase 2, randomized placebo-controlled study [abstract]","volume":"69","author":"Van Vollenhoven","year":"2017","journal-title":"Arthritis Rheumatol"},{"key":"B184","doi-asserted-by":"publisher","first-page":"861028","DOI":"10.1155\/2013\/861028","article-title":"Treatment with anti-interleukin 23 antibody ameliorates disease in lupus-prone mice","volume":"2013","author":"Kyttaris","year":"2013","journal-title":"Biomed Res Int"},{"key":"B185","doi-asserted-by":"publisher","first-page":"222","DOI":"10.1038\/nature14175","article-title":"Clinical improvement in psoriasis with specific targeting of interleukin-23","volume":"521","author":"Kopp","year":"2015","journal-title":"Nature"},{"key":"B186","doi-asserted-by":"publisher","first-page":"276","DOI":"10.1016\/S0140-6736(17)31279-5","article-title":"Tildrakizumab versus placebo or etanercept for chronic plaque psoriasis (reSURFACE 1 and reSURFACE 2): results from two randomised controlled, phase 3 trials","volume":"390","author":"Reich","year":"2017","journal-title":"Lancet"},{"key":"B187","doi-asserted-by":"publisher","first-page":"77","DOI":"10.1053\/j.gastro.2017.03.049","article-title":"Efficacy and safety of MEDI2070, an antibody against interleukin 23, in patients with moderate to severe Crohn\u2019s disease: a phase 2a study","volume":"153","author":"Sands","year":"2017","journal-title":"Gastroenterology"},{"key":"B188","doi-asserted-by":"publisher","first-page":"3567","DOI":"10.4049\/jimmunol.1200143","article-title":"Cutting edge: protein phosphatase 2A confers susceptibility to autoimmune disease through an IL-17-dependent mechanism","volume":"188","author":"Crispin","year":"2012","journal-title":"J Immunol"},{"key":"B189","doi-asserted-by":"publisher","first-page":"16606","DOI":"10.1073\/pnas.1210129109","article-title":"cAMP response element modulator alpha controls IL2 and IL17A expression during CD4 lineage commitment and subset distribution in lupus","volume":"109","author":"Hedrich","year":"2012","journal-title":"Proc Natl Acad Sci U S A"},{"key":"B190","doi-asserted-by":"publisher","first-page":"12993","DOI":"10.1038\/ncomms12993","article-title":"ICER is requisite for Th17 differentiation","volume":"7","author":"Yoshida","year":"2016","journal-title":"Nat Commun"},{"key":"B191","doi-asserted-by":"publisher","first-page":"996","DOI":"10.1172\/JCI22854","article-title":"Systemic lupus erythematosus serum IgG increases CREM binding to the IL-2 promoter and suppresses IL-2 production through CaMKIV","volume":"115","author":"Juang","year":"2005","journal-title":"J Clin Invest"},{"key":"B192","doi-asserted-by":"publisher","first-page":"523","DOI":"10.1002\/art.30085","article-title":"Suppression of autoimmunity and organ pathology in lupus-prone mice upon inhibition of calcium\/calmodulin-dependent protein kinase type IV","volume":"63","author":"Ichinose","year":"2011","journal-title":"Arthritis Rheum"},{"key":"B193","doi-asserted-by":"publisher","first-page":"3490","DOI":"10.4049\/jimmunol.1201785","article-title":"Calcium\/calmodulin-dependent protein kinase IV suppresses IL-2 production and regulatory T cell activity in lupus","volume":"189","author":"Koga","year":"2012","journal-title":"J Immunol"},{"key":"B194","doi-asserted-by":"publisher","first-page":"221","DOI":"10.1016\/j.jdermsci.2017.06.010","article-title":"IL-17 for therapy","volume":"87","author":"Kurschus","year":"2017","journal-title":"J Dermatol Sci"},{"key":"B195","doi-asserted-by":"publisher","first-page":"475","DOI":"10.1002\/art.38955","article-title":"Function of the Th17\/interleukin-17A immune response in murine lupus nephritis","volume":"67","author":"Schmidt","year":"2015","journal-title":"Arthritis Rheumatol"},{"key":"B196","doi-asserted-by":"publisher","first-page":"180","DOI":"10.1038\/nri3156","article-title":"The role of interleukin-2 during homeostasis and activation of the immune system","volume":"12","author":"Boyman","year":"2012","journal-title":"Nat Rev Immunol"},{"key":"B197","doi-asserted-by":"publisher","first-page":"253","DOI":"10.1016\/0092-8674(93)80067-O","article-title":"Ulcerative colitis-like disease in mice with a disrupted interleukin-2 gene","volume":"75","author":"Sadlack","year":"1993","journal-title":"Cell"},{"key":"B198","doi-asserted-by":"publisher","first-page":"3053","DOI":"10.1002\/eji.1830251111","article-title":"Generalized autoimmune disease in interleukin-2-deficient mice is triggered by an uncontrolled activation and proliferation of CD4+ T cells","volume":"25","author":"Sadlack","year":"1995","journal-title":"Eur J Immunol"},{"key":"B199","doi-asserted-by":"publisher","first-page":"1472","DOI":"10.1126\/science.7770771","article-title":"Deregulated T cell activation and autoimmunity in mice lacking interleukin-2 receptor beta","volume":"268","author":"Suzuki","year":"1995","journal-title":"Science"},{"key":"B200","doi-asserted-by":"publisher","first-page":"521","DOI":"10.1016\/1074-7613(95)90180-9","article-title":"Interleukin-2 receptor alpha chain regulates the size and content of the peripheral lymphoid compartment","volume":"3","author":"Willerford","year":"1995","journal-title":"Immunity"},{"key":"B201","doi-asserted-by":"publisher","first-page":"167","DOI":"10.1016\/S1074-7613(02)00367-9","article-title":"CD4 regulatory T cells prevent lethal autoimmunity in IL-2Rbeta-deficient mice. Implications for the nonredundant function of IL-2","volume":"17","author":"Malek","year":"2002","journal-title":"Immunity"},{"key":"B202","doi-asserted-by":"publisher","first-page":"1142","DOI":"10.1038\/ni1263","article-title":"A function for interleukin 2 in Foxp3-expressing regulatory T cells","volume":"6","author":"Fontenot","year":"2005","journal-title":"Nat Immunol"},{"key":"B203","doi-asserted-by":"publisher","first-page":"482","DOI":"10.1016\/j.jaci.2006.10.007","article-title":"CD25 deficiency causes an immune dysregulation, polyendocrinopathy, enteropathy, X-linked-like syndrome, and defective IL-10 expression from CD4 lymphocytes","volume":"119","author":"Caudy","year":"2007","journal-title":"J Allergy Clin Immunol"},{"key":"B204","doi-asserted-by":"publisher","first-page":"371","DOI":"10.1016\/j.immuni.2007.02.009","article-title":"Interleukin-2 signaling via STAT5 constrains T helper 17 cell generation","volume":"26","author":"Laurence","year":"2007","journal-title":"Immunity"},{"key":"B205","doi-asserted-by":"publisher","first-page":"770","DOI":"10.1038\/ni.2363","article-title":"Aiolos promotes TH17 differentiation by directly silencing Il2 expression","volume":"13","author":"Quintana","year":"2012","journal-title":"Nat Immunol"},{"key":"B206","doi-asserted-by":"publisher","first-page":"690","DOI":"10.1016\/j.immuni.2015.08.017","article-title":"The interleukin-2-mTORc1 kinase axis defines the signaling, differentiation, and metabolism of T helper 1 and follicular B helper T cells","volume":"43","author":"Ray","year":"2015","journal-title":"Immunity"},{"key":"B207","doi-asserted-by":"publisher","first-page":"858","DOI":"10.1038\/353858a0","article-title":"Interleukin-2 programs mouse alpha beta T lymphocytes for apoptosis","volume":"353","author":"Lenardo","year":"1991","journal-title":"Nature"},{"key":"B208","doi-asserted-by":"publisher","first-page":"615","DOI":"10.1016\/S1074-7613(00)80566-X","article-title":"Biochemical mechanisms of IL-2-regulated Fas-mediated T cell apoptosis","volume":"8","author":"Refaeli","year":"1998","journal-title":"Immunity"},{"key":"B209","doi-asserted-by":"publisher","first-page":"791","DOI":"10.1084\/jem.154.3.791","article-title":"Analysis of T cell function in autoimmune murine strains. Defects in production and responsiveness to interleukin 2","volume":"154","author":"Altman","year":"1981","journal-title":"J Exp Med"},{"key":"B210","doi-asserted-by":"publisher","first-page":"1388","DOI":"10.1172\/JCI110579","article-title":"Decreased production of and response to interleukin-2 by cultured lymphocytes from patients with systemic lupus erythematosus","volume":"69","author":"Alcocer-Varela","year":"1982","journal-title":"J Clin Invest"},{"key":"B211","doi-asserted-by":"crossref","first-page":"2651","DOI":"10.4049\/jimmunol.130.6.2651","article-title":"Defective production of interleukin 1 and interleukin 2 in patients with systemic lupus erythematosus (SLE)","volume":"130","author":"Linker-Israeli","year":"1983","journal-title":"J Immunol"},{"key":"B212","doi-asserted-by":"publisher","first-page":"9358","DOI":"10.1073\/pnas.93.18.9358","article-title":"A dynamic assembly of diverse transcription factors integrates activation and cell-type information for interleukin 2 gene regulation","volume":"93","author":"Rothenberg","year":"1996","journal-title":"Proc Natl Acad Sci U S A"},{"key":"B213","doi-asserted-by":"publisher","first-page":"3557","DOI":"10.4049\/jimmunol.173.5.3557","article-title":"Cyclic adenosine 5\u2019-monophosphate response element modulator is responsible for the decreased expression of c-fos and activator protein-1 binding in T cells from patients with systemic lupus erythematosus","volume":"173","author":"Kyttaris","year":"2004","journal-title":"J Immunol"},{"key":"B214","doi-asserted-by":"publisher","first-page":"118","DOI":"10.1016\/j.autrev.2005.08.009","article-title":"Transcriptional repression of interleukin-2 in human systemic lupus erythematosus","volume":"5","author":"Katsiari","year":"2006","journal-title":"Autoimmun Rev"},{"key":"B215","doi-asserted-by":"publisher","first-page":"3193","DOI":"10.1172\/JCI24895","article-title":"Protein phosphatase 2A is a negative regulator of IL-2 production in patients with systemic lupus erythematosus","volume":"115","author":"Katsiari","year":"2005","journal-title":"J Clin Invest"},{"key":"B216","doi-asserted-by":"publisher","first-page":"4268","DOI":"10.4049\/jimmunol.1601705","article-title":"Downregulation of miR-200a-3p, targeting CtBP2 complex, is involved in the hypoproduction of IL-2 in systemic lupus erythematosus-derived T cells","volume":"198","author":"Katsuyama","year":"2017","journal-title":"J Immunol"},{"key":"B217","doi-asserted-by":"publisher","first-page":"2055","DOI":"10.1056\/NEJMoa1108188","article-title":"Interleukin-2 and regulatory T cells in graft-versus-host disease","volume":"365","author":"Koreth","year":"2011","journal-title":"N Engl J Med"},{"key":"B218","doi-asserted-by":"publisher","first-page":"179ra143","DOI":"10.1126\/scitranslmed.3005265","article-title":"Low-dose interleukin-2 therapy restores regulatory T cell homeostasis in patients with chronic graft-versus-host disease","volume":"5","author":"Matsuoka","year":"2013","journal-title":"Sci Transl Med"},{"key":"B219","doi-asserted-by":"publisher","first-page":"295","DOI":"10.1016\/S2213-8587(13)70113-X","article-title":"Low-dose interleukin 2 in patients with type 1 diabetes: a phase 1\/2 randomised, double-blind, placebo-controlled trial","volume":"1","author":"Hartemann","year":"2013","journal-title":"Lancet Diabetes Endocrinol"},{"key":"B220","doi-asserted-by":"publisher","first-page":"2067","DOI":"10.1056\/NEJMoa1105143","article-title":"Regulatory T-cell responses to low-dose interleukin-2 in HCV-induced vasculitis","volume":"365","author":"Saadoun","year":"2011","journal-title":"N Engl J Med"},{"key":"B221","doi-asserted-by":"publisher","first-page":"791","DOI":"10.1136\/annrheumdis-2014-206506","article-title":"Rapid induction of clinical remission by low-dose interleukin-2 in a patient with refractory SLE","volume":"74","author":"Humrich","year":"2015","journal-title":"Ann Rheum Dis"},{"key":"B222","doi-asserted-by":"publisher","first-page":"991","DOI":"10.1038\/nm.4148","article-title":"Low-dose interleukin-2 treatment selectively modulates CD4(+) T cell subsets in patients with systemic lupus erythematosus","volume":"22","author":"He","year":"2016","journal-title":"Nat Med"},{"key":"B223","doi-asserted-by":"publisher","first-page":"68","DOI":"10.1007\/s11926-016-0617-5","article-title":"Low-dose IL-2 in the treatment of lupus","volume":"18","author":"Mizui","year":"2016","journal-title":"Curr Rheumatol Rep"},{"key":"B224","doi-asserted-by":"publisher","first-page":"2168","DOI":"10.4049\/jimmunol.1400977","article-title":"IL-2 protects lupus-prone mice from multiple end-organ damage by limiting CD4-CD8- IL-17-producing T cells","volume":"193","author":"Mizui","year":"2014","journal-title":"J Immunol"},{"key":"B225","doi-asserted-by":"publisher","first-page":"1407","DOI":"10.1136\/annrheumdis-2015-207776","article-title":"Low-dose interleukin-2 selectively corrects regulatory T cell defects in patients with systemic lupus erythematosus","volume":"75","author":"von Spee-Mayer","year":"2016","journal-title":"Ann Rheum Dis"},{"key":"B226","doi-asserted-by":"publisher","first-page":"808","DOI":"10.1002\/art.40014","article-title":"Brief report: CD4+ T cells from patients with systemic lupus erythematosus respond poorly to exogenous interleukin-2","volume":"69","author":"Comte","year":"2017","journal-title":"Arthritis Rheumatol"},{"key":"B227","doi-asserted-by":"publisher","first-page":"9321","DOI":"10.1073\/pnas.1605081113","article-title":"Engagement of SLAMF3 enhances CD4+ T-cell sensitivity to IL-2 and favors regulatory T-cell polarization in systemic lupus erythematosus","volume":"113","author":"Comte","year":"2016","journal-title":"Proc Natl Acad Sci U S A"},{"key":"B228","doi-asserted-by":"publisher","first-page":"1875","DOI":"10.1084\/jem.20030152","article-title":"Conversion of peripheral CD4+CD25- naive T cells to CD4+CD25+ regulatory T cells by TGF-beta induction of transcription factor Foxp3","volume":"198","author":"Chen","year":"2003","journal-title":"J Exp Med"},{"key":"B229","doi-asserted-by":"publisher","first-page":"632","DOI":"10.1038\/ni.1607","article-title":"A critical function for TGF-beta signaling in the development of natural CD4+CD25+Foxp3+ regulatory T cells","volume":"9","author":"Liu","year":"2008","journal-title":"Nat Immunol"},{"key":"B230","doi-asserted-by":"publisher","first-page":"6961","DOI":"10.1073\/pnas.1304498110","article-title":"Excessive Th1 responses due to the absence of TGF-beta signaling cause autoimmune diabetes and dysregulated Treg cell homeostasis","volume":"110","author":"Ishigame","year":"2013","journal-title":"Proc Natl Acad Sci U S A"},{"key":"B231","doi-asserted-by":"publisher","first-page":"E7536","DOI":"10.1073\/pnas.1706356114","article-title":"Foxp3-independent mechanism by which TGF-beta controls peripheral T cell tolerance","volume":"114","author":"Oh","year":"2017","journal-title":"Proc Natl Acad Sci U S A"},{"key":"B232","doi-asserted-by":"publisher","first-page":"179","DOI":"10.1016\/j.immuni.2006.01.001","article-title":"TGFbeta in the context of an inflammatory cytokine milieu supports de novo differentiation of IL-17-producing T cells","volume":"24","author":"Veldhoen","year":"2006","journal-title":"Immunity"},{"key":"B233","doi-asserted-by":"publisher","first-page":"967","DOI":"10.1038\/nature09447","article-title":"Generation of pathogenic T(H)17 cells in the absence of TGF-beta signalling","volume":"467","author":"Ghoreschi","year":"2010","journal-title":"Nature"},{"key":"B234","doi-asserted-by":"publisher","first-page":"2039","DOI":"10.3899\/jrheum.100180","article-title":"Levels of transforming growth factor-beta are low in systemic lupus erythematosus patients with active disease","volume":"37","author":"Becker-Merok","year":"2010","journal-title":"J Rheumatol"},{"key":"B235","doi-asserted-by":"publisher","first-page":"477","DOI":"10.1007\/s10875-011-9637-0","article-title":"Activity of childhood lupus nephritis is linked to altered T cell and cytokine homeostasis","volume":"32","author":"Edelbauer","year":"2012","journal-title":"J Clin Immunol"},{"key":"B236","doi-asserted-by":"publisher","first-page":"70","DOI":"10.1186\/s13075-017-1238-8","article-title":"Excessive activation of the TLR9\/TGF-beta1\/PDGF-B pathway in the peripheral blood of patients with systemic lupus erythematosus","volume":"19","author":"Yuan","year":"2017","journal-title":"Arthritis Res Ther"},{"key":"B237","doi-asserted-by":"publisher","first-page":"574","DOI":"10.1007\/s10875-011-9531-9","article-title":"Resistance to exogenous TGF-beta effects in patients with systemic lupus erythematosus","volume":"31","author":"Elbeldi-Ferchiou","year":"2011","journal-title":"J Clin Immunol"},{"key":"B238","doi-asserted-by":"publisher","first-page":"6329","DOI":"10.1038\/ncomms7329","article-title":"TGF-beta3-expressing CD4+CD25(-)LAG3+ regulatory T cells control humoral immune responses","volume":"6","author":"Okamura","year":"2015","journal-title":"Nat Commun"},{"key":"B239","doi-asserted-by":"publisher","first-page":"E8131","DOI":"10.1073\/pnas.1611286114","article-title":"Egr2 and Egr3 in regulatory T cells cooperatively control systemic autoimmunity through Ltbp3-mediated TGF-beta3 production","volume":"113","author":"Morita","year":"2016","journal-title":"Proc Natl Acad Sci U S A"},{"key":"B240","doi-asserted-by":"publisher","first-page":"163","DOI":"10.1002\/1529-0131(200201)46:1<163::AID-ART10065>3.0.CO;2-J","article-title":"Abnormal expression of various molecular forms and distribution of T cell receptor zeta chain in patients with systemic lupus erythematosus","volume":"46","author":"Nambiar","year":"2002","journal-title":"Arthritis Rheum"}],"container-title":["Frontiers in Immunology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/article\/10.3389\/fimmu.2018.01088\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,9,2]],"date-time":"2023-09-02T13:58:38Z","timestamp":1693663118000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/article\/10.3389\/fimmu.2018.01088\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,5,17]]},"references-count":240,"alternative-id":["10.3389\/fimmu.2018.01088"],"URL":"https:\/\/doi.org\/10.3389\/fimmu.2018.01088","relation":{},"ISSN":["1664-3224"],"issn-type":[{"value":"1664-3224","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,5,17]]},"article-number":"1088"}}